Knollwood Investment Advisory, LLC

Position in CAI — Caris Life Sciences, Inc.

CIK 1999346 HUNT VALLEY, MD

Position in CAI

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$186,129

-$627 QoQ

Shares Held

10,445

0.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#174

of 246 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Knollwood Investment Advisory, LLC holds $8,491,864 across 5 Biotechnology names. CAI ranks #5 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABOS	Acumen Pharmaceuticals, Inc.	1,628,510	$4,348,121
2	VRTX	Vertex Pharmaceuticals Inc / Ma	4,988	$2,477,689
3	ARGX	Argenx SE	1,379	$1,279,394
4	GMAB	Genmab A/S	7,300	$200,531
5	CAI	Caris Life Sciences, Inc. This page	10,445	$186,129

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$186,129	10,445	0.0%	Shares	Sole	2026-08-13
2026-03-31	$186,756	10,445	0.0%	Shares	Sole	2026-05-14
2025-12-31	$281,806	10,445	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.